Biohaven Ltd.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Biohaven Ltd.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
No other changes.
No thesis.
Annual filing, covered
10-K parsed · Mar 2 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 2 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
−6.49%
vs ±14.7% implied · ×0.44
shaded = implied · ▲▼ = realized
Biohaven Ltd.
15.16
pre 15.79 +1.15%
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $196.6M | 9.16% | +17.72% |
| Suvretta | $153.1M | 7.13% | 0.00% |
| Stifel Financial | $147.9M | 6.89% | 0.00% |
| Jupiter Topco | $127.9M | 5.96% | — |
| Woodline Partners | $114.0M | 5.31% | +2450.12% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $196.6M | 9.16% | +17.72% |
| Suvretta | $153.1M | 7.13% | 0.00% |
| Stifel Financial | $147.9M | 6.89% | 0.00% |
| Jupiter Topco | $127.9M | 5.96% | — |
| Woodline Partners | $114.0M | 5.31% | +2450.12% |
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of Biohaven Ltd.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; of Biohaven Ltd.'s 6 closest co-movers, none share that code.
Bull2
Bear0
—
Linked news
Tall tick = annual report · Source: EDGAR
—
Expected move
Inputsspot 15.61exp Mar 19ATM strike 16ATM straddle 6.65IV 88%